These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3677678)

  • 21. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats.
    Durand P; Blache D
    Atherosclerosis; 1996 Apr; 121(2):205-16. PubMed ID: 9125295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VII activation and oral contraceptives.
    Plu-Bureau G; Scarabin PY; Bara L; Malmejac A; Guize L; Samama M
    Thromb Res; 1993 May; 70(3):275-80. PubMed ID: 8327993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations.
    Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA
    Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of oestrogen administration on the plasma free protein S and C4b-binding protein.
    Melissari E; Kakkar VV
    Thromb Res; 1988 Mar; 49(5):489-95. PubMed ID: 2967557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
    Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate metabolism of Indian women taking steroid contraceptives.
    Barsivala VM; Virkar K; Kulkarni RD
    Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
    Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
    Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill.
    Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ
    Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of 14-C-arachidonic acid in platelets and antiaggregatory potency of prostacyclin in women taking oral contraceptives.
    Jaschonek K; Michalski U; Daiss W; Ostendorf P
    Prostaglandins Leukot Med; 1984 Aug; 15(2):275-6. PubMed ID: 6436834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.